Clinical value of left atrial appendage flow velocity for predicting of cardioversion success in patients with non-valvular atrial fibrillation.

BACKGROUND Echocardiographic parameters for predicting cardioversion outcome in patients with non-valvular atrial fibrillation are not accurately defined. OBJECTIVE To evaluate the role of left atrial appendage flow velocity detected by transoesophageal echocardiography for prediction of cardioversion outcome in patients with non-valvular atrial fibrillation enrolled in a prospective. multicentre, international study. METHODS Four hundred and eight patients (257 males, mean age: 66 +/- 10 years) with non-valvular atrial fibrillation lasting more than 48 h but less than 1 year underwent transthoracic echocardiography and transoesophageal echocardiography before either electrical (n=324) or pharmacological (n=84) cardioversion. RESULTS Cardioversion was successful in restoring sinus rhythm in 328 (80%) and unsuccessful in 80 patients (20%). Mean left atrial appendage peak emptying flow velocity was significantly higher in patients with successful than in those with unsuccessful cardioversion (32.4 +/- 17.7 vs 23.5 +/- 13.6 cm x s(-1); P<0.0001). At multivariate logistic regression analysis, three parameters proved to be independent predictors of cardioversion success: the atrial fibrillation duration <2 weeks (P=0.011, OR=4.9, CI 95%=1.9-12.7), the mean left atrial appendage flow velocity >31 cm x s(-1) (P=0.0013, OR=2.8, CI 95%=1.5-5.4) and the left atrial diameter <47 mm (P=0.093, OR=2.0, CI 95%=1.2-3.4). These independent predictors of cardioversion success outperformed other univariate predictors such as left ventricular end-diastolic diameter <58 mm, ejection fraction >56% and the absence of left atrial spontaneous echo contrast. CONCLUSION In patients with non-valvular atrial fibrillation, measurement of the left atrial appendage flow velocity profile by transoesophageal echocardiography before cardioversion provides valuable information for prediction of cardioversion outcome.

[1]  W. Henry,et al.  Relation between Echocardiographically Determined Left Atrial Size and Atrial Fibrillation , 1976, Circulation.

[2]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[3]  W. Daniel,et al.  Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. , 1988, Journal of the American College of Cardiology.

[4]  M. Brodsky,et al.  Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. , 1989, The American journal of cardiology.

[5]  T. Savides,et al.  Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. , 1989, The American journal of cardiology.

[6]  T. Akasaka,et al.  Assessment of Mitral Regurgitation by Biplane Transesophageal Color Doppler Flow Mapping , 1990, Circulation.

[7]  H. Crijns,et al.  Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. , 1991, The American journal of cardiology.

[8]  C. Pollick,et al.  Assessment of Left Atrial Appendage Function by Transesophageal Echocardiography: Implications for the Development of Thrombus , 1991, Circulation.

[9]  H. Krumholz,et al.  Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. , 1993, The New England journal of medicine.

[10]  L. Lai,et al.  Clinical implications of left atrial appendage flow patterns in nonrheumatic atrial fibrillation. , 1994, Chest.

[11]  D. Fatkin,et al.  Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. , 1994, Journal of the American College of Cardiology.

[12]  J. Gardin,et al.  Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). , 1994, The American journal of cardiology.

[13]  A. Sheikhzadeh,et al.  Relation of left atrial appendage function to the duration and reversibility of nonvalvular atrial fibrillation. , 1995, The American journal of cardiology.

[14]  S. Ito,et al.  Evaluation of left atrial appendage function by measurement of changes in flow velocity patterns after electrical cardioversion in patients with isolated atrial fibrillation. , 1997, The American journal of cardiology.

[15]  O. Kamp,et al.  Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation. , 1997, The American journal of cardiology.

[16]  A. Castaigne,et al.  Is left atrial appendage flow a predictor for outcome of cardioversion of nonvalvular atrial fibrillation? A transthoracic and transesophageal echocardiographic study , 1997 .

[17]  C. Visser,et al.  Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation. , 1999, European heart journal.

[18]  B K Khandheria,et al.  Echocardiographic assessment of the left atrial appendage. , 1999, Journal of the American College of Cardiology.

[19]  C. Tracy,et al.  American College of Cardiology/American Heart Association Clinical Competence Statement on invasive electrophysiology studies, catheter ablation, and cardioversion: A report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal M , 2000, Circulation.

[20]  M Akhtar,et al.  American College of Cardiology/american Heart Association Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion a Report of the American College of Cardiology/american Heart Association/american College of Physicians–american Society of Internal Me , 2022 .

[21]  M. Brodsky,et al.  Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study , 2000, Circulation.

[22]  R. D. Murray,et al.  Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. , 2001, Journal of the American College of Cardiology.

[23]  A. Labovitz,et al.  Evolving role of echocardiography in the management of atrial fibrillation. , 2001, American heart journal.

[24]  B. Gersh,et al.  Epidemiology and natural history of atrial fibrillation: clinical implications. , 2001, Journal of the American College of Cardiology.